EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Performance of a Novel Plasmodium falciparum Rapid Diagnostic Test in Areas of Widespread hrp2/3 Gene Deletion

Aynalem Mandefro iD, Xavier C Ding iD, Jocelyn Farge, Gezahegn Solomon Alemayehu, Geletta Tadele, Bacha Mekonen, Yirgalem Gebrehiwot, Nega Berhe iD, Berhanu Erko, Hannah C Slater iD, Greg T Bizilj, Rebecca Barney und 3 weitere

Clinical Infectious Diseases · 04.02.2026 · 81 (6) · e491-e501

DOI: 10.1093/cid/ciaf212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 24.04.2025. Verfasst von Aynalem Mandefro und 14 weiteren Autor:innen. Beteiligte Einrichtung: Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Protozoan Proteins, Antigens, Protozoan, Malaria, Falciparum, Plasmodium falciparum. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rapid diagnostic tests (RDTs) have improved malaria diagnosis; however, the emergence of hrp2/3 gene deletions threatens the reliability of HRP2-based RDTs. This study evaluated the diagnostic performance of a novel RDT detecting both HRP2 and PfLDH in a single test line.

Method

A cross-sectional study was conducted at two health centers in Ethiopia, recruiting 1004 study participants. Blood samples were tested using the novel and comparator RDTs, using microscopy and nested polymerase chain reaction (PCR) as the reference standards. Plasmodium falciparum hrp2 and hrp3 genotyping and HRP2 and P. falciparum lactate dehydrogenase (PfLDH) antigen quantification were also conducted.

Results

In this study setting, characterized by 80% of P. falciparum infections showing hrp2 or hrp3 deletion, the novel RDT showed a sensitivity of 77.4% and a specificity of 96%, surpassing the HRP2-only comparators Bioline™ Malaria Ag Pf (55.9%) and Bioline™ Malaria Ag Pf/Pv (56.8%). Its performance was comparable to the three-line Bioline™ Malaria Ag Pf/Pf/Pv RDT, which detects HRP2, PfLDH, and PvLDH, at 77.7% sensitivity. Additionally, the novel RDT exhibited the ability to detect P. falciparum cases across a broader range of HRP2 and PfLDH antigen concentrations compared to the comparator RDTs.

Conclusions

The single-line, easy-to-interpret index malaria RDT outperforms conventional HRP2-only RDTs, making it a promising tool for enhancing malaria diagnosis in regions with high hrp2/3 deletion prevalence. Clinical Trial Registration. The study is registered on ClinicalTrials.gov ID NCT05286359.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protozoan ProteinsAntigens, ProtozoanMalaria, FalciparumPlasmodium falciparumGene DeletionDiagnostic Tests, RoutineHumansCross-Sectional StudiesSensitivity and SpecificityFemaleMaleAdultEthiopiaYoung AdultAdolescentChild, PreschoolChildMiddle AgedL-Lactate DehydrogenaseGenotypeInfantRapid Diagnostic Tests

Stichwörter der Autor:innen

P. falciparumEthiopiaHRP2/3novelrapid diagnostic test

Substanzen

Protozoan ProteinsAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumHRP3 protein, Plasmodium falciparumL-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
  • College of Natural and Computational Sciences, Hawasa University, Hawasa, Ethiopia.
  • Abbott Rapid Diagnostics Infectious Disease, Baar, Switzerland.
  • Abbott Rapid Diagnostics Infectious Disease, Bievres, France.
  • Ethiopian Defence University College of Health Sciences, Bishoftu, Ethiopia.
  • Institute of Health Science, Wollega University, Nekemte, Ethiopia.

ORCID-Profile: Aynalem Mandefro, Xavier C Ding, Nega Berhe, Hannah C Slater, Gonzalo J Domingo

Zitieren

APA

Mandefro, A., Ding, X. C., Farge, J., Alemayehu, G. S., Tadele, G., Mekonen, B., Gebrehiwot, Y., Berhe, N., Erko, B., Slater, H. C., Bizilj, G. T., Barney, R., Golden, A., Domingo, G. J., & Golassa, L. (2026). Performance of a Novel Plasmodium falciparum Rapid Diagnostic Test in Areas of Widespread hrp2/3 Gene Deletion. Clinical Infectious Diseases, 81(6), e491-e501. https://doi.org/10.1093/cid/ciaf212

Vancouver

Mandefro A, Ding XC, Farge J, Alemayehu GS, Tadele G, Mekonen B, et al. Performance of a Novel Plasmodium falciparum Rapid Diagnostic Test in Areas of Widespread hrp2/3 Gene Deletion. Clinical Infectious Diseases. 2026;81(6):e491-e501. doi:10.1093/cid/ciaf212

BibTeX
@article{Mandefro2026,
  author = {Mandefro, Aynalem and Ding, Xavier C and Farge, Jocelyn and Alemayehu, Gezahegn Solomon and Tadele, Geletta and Mekonen, Bacha and Gebrehiwot, Yirgalem and Berhe, Nega and Erko, Berhanu and Slater, Hannah C and Bizilj, Greg T and Barney, Rebecca and Golden, Allison and Domingo, Gonzalo J and Golassa, Lemu},
  title = {Performance of a Novel Plasmodium falciparum Rapid Diagnostic Test in Areas of Widespread hrp2/3 Gene Deletion},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {81},
  number = {6},
  pages = {e491--e501},
  doi = {10.1093/cid/ciaf212}
}
Kostenlos starten →